¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"elbow fat pad sign"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • sign language
    ½Åȣȭ¾ð¾î
  • sign test
    ºÎÈ£°ËÁ¤
  • silhouette sign
    ½Ç·ç¿§Â¡ÈÄ
  • target sign
    Ç¥Àû¡ÈÄ
  • vital sign
    Ȱ·Â¡ÈÄ
  • warning sign
    °æ°è¡ÈÄ, ÁÖÀÇ¡ÈÄ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • myotactic irritability sign
    ±ÙÀ°°¨°¢ÈïºÐ¡ÈÄ
  • naked facet sign
    °üÀýµ¹±â³ëÃâ¡ÈÄ
  • niche sign
    º®¿À¸ñ¡ÈÄ
  • objective sign
    Ÿ°¢Â¡ÈÄ
  • obturator sign
    Æó¼â±Ù¡ÈÄ
  • painful shoulder sign
    ¾î±úÅëÁõ¡ÈÄ, °ß°©Åë¡ÈÄ
  • palmoplantar sign
    ¼Õ¹ß¹Ù´Ú¡ÈÄ
  • parallel channel sign
    ÆòÇà°ü¡ÈÄ
  • peroneal sign
    Á¾¾Æ¸®Â¡ÈÄ, ºñ°ñ¡ÈÄ
  • phlebothrombosis sign
    Á¤¸ÆÇ÷Àü¡ÈÄ
  • piano percussion sign
    ÇǾƳ뿬ÁÖ¡ÈÄ
  • plus sign
    Ãß°¡Â¡ÈÄ
  • presumptive sign
    ÀÓ½ÅÃßÁ¤Â¡ÈÄ
  • probable sign
    ÀӽŰ¡´É¡ÈÄ
  • pronation sign
    ¾þħ¡ÈÄ, ȸ³»Â¡ÈÄ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • perirenal fat
    ½ÅÁÖÀ§Áö¹æ
  • phase evolution of fat suppression
    À§»ó ¼±È¸ Áö¹æ ¾ïÁ¦
  • subcutaneous fat
    ÇÇÇÏÁö¹æ.
  • subcutaneous fat necrosis
    ÇÇÇÏÁö¹æ±«»ç (¡­ò·Û¸ÎÕÞÝ).
  • subcutaneous fat necrosis
    ÇÇÇÏÁö¹æ±«»ç(¡­ò·Û¸ÎÕÞÝ)
  • subcutaneous fat necrosis of newborn
    ½Å»ý¾ÆÇÇÇÏÁö¹æ±«»ç.
  • subcutaneous fat necrosis of newborn
    ½Å»ý¾ÆÇÇÇÏÁö¹æ±«»ç(ãæßæä®ù«ù»ò·Û¸ÎÕÞÝ)
  • traumatic fat necrosis
    ¿Ü»ó¼º Áö¹æ±«»ç(¡­ò·Û¸ÎÕÞÝ)
  • triceps fat fold
  • unilocular fat cell
    ȬĭÁö¹æ¼¼Æ÷
  • vitamin,fat soluble
    Áö¿ë¼º(ò·éÁàõ)
  • white fat tissue
    ¹é»öÁö¹æÁ¶Á÷(ÛÜßäò·Û¸ ðÚòÄ).
  • white fat tissue
    ¹é»öÁö¹æÁ¶Á÷
  • accessory sign
    Á¾¼Ó¡ÈÄ(ðôáÕó£ý¦), ºÎ¡ÈÄ.
  • air dome sign
    °ø±âµ¼ ¡ÈÄ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
FAT family attitudes test; fluorescent antibody technique; fluorescent antibody test
FES family environment scale; fat embolism syndrome; flame emission spectroscopy; forced expiratory spir...
FF degree of fineness of abrasive particles; fat-free; father factor; fecal frequency; fertility factor...
FFDW fat-free dry weight
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
FBM fat body mass
FCM fat corrected milk
%FTM fat tissue mass
HF high fat diet
LF low fat diet
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pseudokidney sign
    °¡¼º ½Å ¡ÈÄ
  • pyramidal sign
    Ãßü·Î ¡ÈÄ
  • Raynaud's sign
    ·¹À̳ë ¡ÈÄ
    »çÁöÀÇ ´ëĪÀû û»öÁõÀ» Ư¡À¸·Î ÇÏ´Â Áõ»óÀ¸·Î¼­ ¼Õ°¡¶ô, ¼Õ¸ñ µîÀÇ ÇǺΰ¡ Áö¼ÓÀûÀ¸·Î û»ö°ú Àû»öÀ¸·Î º¯ÇÏ°í ¼Õ°¡¶ôÀÇ ´ë·® ¹ßÇѰú ³Ã°¢À» ¼ö¹ÝÇÑ´Ù.
  • sagging rope sign
    ´Ã¾îÁø Á٠¡ÈÄ
  • scarf sign
    ½ºÄ«ÇÁ ¡ÈÄ
    ¹Ì¼÷¾ÆÀÇ ÆÈ²ÞÄ¡°¡ ½±°Ô °¡½¿À» °¡·ÎÁú·¯ ´ê´Â ¡ÈÄ.
  • scimitar sign
    ½Å¿ùµµ ¡ÈÄ
  • shell sign
    Á¶°³ ²®Áú ¡ÈÄ
  • Sicar's sign
    ½ÃÄ«¸£ ¡ÈÄ
    Èä°­ »ïÃâÀÇ Â¡Èķμ­, 2°³ÀÇ °æÈ­¸¦ ŸÁøÃß¿Í Å¸ÁøÆÇ ´ë½ÅÀ¸·Î »ç¿ëÇÏ¿© ÀüÈäºÎ¸¦ ŸÁøÇϰí, À̰ÍÀ» µî ÂÊ¿¡¼­ ûÁøÇÏ¸é ±Ý¼Ó¼ºÀÇ °ø¸íÀ½ÀÌ µé¸°´Ù.
  • Siegert's sign
    Áö°Ô¸£Æ® ¡ÈÄ
    ¸ù°íÁõ¿¡¼­ º¼ ¼ö ÀÖ´Â »õ³¢¼Õ°¡¶ôÀÌ Âª°í ÷´ÜÀÌ ³»¹ÝÇÑ °Í.
  • sign language
    ¸öÁþ ¾ð¾î
  • sign test
    ºÎÈ£ °ËÁ¤
  • Signorelli's sign
    ½Ã´¢·¼¸® ¡ÈÄ
    ¼ö¸·¿°¿¡¼­ º¼ ¼ö ÀÖ´Â °ÍÀ¸·Î¼­, ÇÏ¾Ç ÈÄÁ¡À» ¾Ð¹ÚÇÏ¸é °ÝÅëÀ» ´À³¤´Ù.
  • silhouette sign
    ½Ç·ç¿§ ¡ÈÄ
  • Simon's sign
    ½Ã¸ó ¡ÈÄ
    ¼ûÀ» µéÀÌ ½¯ ¶§¿¡ º¼ ¼ö ÀÖ´Â ¹è²ÅÀÇ ÅðÃà ¶Ç´Â °íÁ¤, ȤÀº ¼ö¸·¿°¿¡¼­ º¼ ¼ö ÀÖ´Â Èä°û°ú Ⱦ°æ¸· ¿îµ¿ÀÇ »ó°ü¼ºÀÇ °á¿©.
  • Skeer's sign
    ½ºÅ°¾î ÁõÈÄ
    °áÇÙ¼º ¼ö¸·¿°¿¡¼­, ¾çÂÊ µ¿°ø °¡±îÀÌ¿¡ Àִ ȫä¿¡ Ȳ°¥»öÀ» ¶í ÀÛÀº ȯÀÌ »ý±â´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
fat soluble <chemistry> Can be dissolved in fat. Lipid soluble
(27 Sep 1997)
fat-soluble vitamins Those vitamin's, soluble in fat solvents (nonpolar solvents) and relatively insoluble in water, marked in chemical structure by the presence of large hydrocarbon moieties in the molecule; e.g., vitamin's A, D, E, K.
(05 Mar 2000)
fat solvents Organic liquids notable for their ability to dissolve lipids; usually, but not always, immiscible in water; e.g., diethyl ether, carbon tetrachloride.
Synonym: nonpolar solvents.
(05 Mar 2000)
fat-storing cell A multilocular fat-filled cell present in the perisinusoidal space in the liver.
Synonym: lipocyte.
(05 Mar 2000)
fat substitutes Compounds used in food or in food preparation to replace dietary fats. They may be carbohydrate-, protein-, or fat-based. Fat substitutes are usually lower in calories but provide the same texture as fats.
(12 Dec 1998)
fat tide An increase in the fat content of blood and lymph following a meal.
(05 Mar 2000)
unilocular fat Adipose tissue in which the fat is present in a single droplet within the fat cells.
Synonym: white fat.
(05 Mar 2000)
unsaturated fat <biochemistry> A fat that contains a carbon-carbon double bond, or a fat containing unsaturated fatty acids, such a fatty acid has double or triple covalent bonds and is thus able to add more atoms. Unsaturated fats are believed to lower blood cholesterol levels and are found at high levels in vegetable oils (olive oil, safflower oil, etc.) As a general rule, unsaturated fats are liquid at room temperature.
(09 Oct 1997)
low-fat diet A diet containing minimal amounts of fat.Diets containing low amounts of fat and cholesterol are designed to reduce the risk of heart disease and, in some cases, cancer. Dozens of such diets have been promulgated, both by medical and lay advisors. Their popularity can be attributed in part to clinical studies that have, since the 1980s, revealed, on the one hand, the hazards of eating high-fat, high-cholesterol foods and, on the other, the benefits of ingesting less saturated fat and LDL (low density lipoprotein) cholesterol. Although coronary deaths have been reduced by roughly 30% since 1970, the aim of health officials is to further reduce heart attack rates. The average cholesterol level among adult Americans has fallen from 213 to 205 mg/dl since 1978. However, the National Cholesterol Education Program recommends that individuals maintain a total cholesterol level of no more than 200 mg/dl, with LDL at less than 130 mg/dl and HDL (high density lipoprotein) around 60 mg/dl. About one-half of American adults exceed those recommendations. Low-fat, low-cholesterol diets are rich in whole grains, fresh fruits and vegetables, and legumes, and limit or exclude consumption of processed oils, dairy products, nuts and seeds, and meats. See atherosclerosis, free radicals.
(05 Mar 2000)
Aaron's sign <clinical sign> In acute appendicitis, a referred pain or feeling of distress in the epigastrium or precordial region on continuous firm pressure over McBurney's point.
(05 Mar 2000)
Abadie's sign of tabes dorsalis Insensibility to pressure over the tendo achillis.
(05 Mar 2000)
Abrahams' sign <clinical sign> An obsolete sign:
Rales and other adventitious sounds, changes in the respiratory murmurs, and increase in the whispered sound can be heard on auscultation over the acromial end of the clavicle some time before they become audible at the apex; heard primarily in pulmonary tuberculosis affecting the apical portion of the lung, a dull-flat note, i.e., one between the normal dullness at the right apex and absolute flatness, heard on percussion in that region, indicating progress from incipient to advanced tuberculosis.
(05 Mar 2000)
accessory sign <clinical sign> A finding frequently but not consistently present in a disease.
Synonym: assident sign.
(05 Mar 2000)
Allis' sign <clinical sign> In fracture of the neck of the femur, the trochanter rides up, relaxing the fascia lata, so that the finger can be sunk deeply between the great trochanter and the iliac crest.
(05 Mar 2000)
Amoss' sign <clinical sign> In painful flexion of the spine, it is necessary to support a sitting position by extending the arms behind the torso with the weight placed on the hands.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á